ACTIVE

CREDOPHAR

Financial year 2025 · closed on 31/12/2025
Net result
51,7 k €
+128.3% YoY
Gross margin
257,7 k €
+134.3% YoY
Equity
1,9 M €
+2.8% YoY

What does CREDOPHAR do?

CREDOPHAR is a Private limited company incorporated in 2012. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0849.730.193
Incorporation
16/10/2012
Legal form
Private limited company
Registered office
Kortrijksesteenweg 1091 box B
9051 Gent · FlandreSee on map
Contributed capital
20 521,52 €
Latest accounts
31/12/2025
Joint committees (2)
  • 100
  • 200
Contacts
2 public details availableLog in to view
Signals
ProfitablePositive cashflowPositive EBITDA
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 13 financial years

2025202420232022202120202019201820172016201620152014
Income statement
Gross margin257,7 k €110 k €514,4 k €1,1 M €1,4 M €1,3 M €1,2 M €1,1 M €980,1 k €355,1 k €598,9 k €347,8 k €123,9 k €
EBITDA255,1 k €70,2 k €507,5 k €583,8 k €951,1 k €670,8 k €551,1 k €538,5 k €486,4 k €138,3 k €183 k €52,1 k €-101 k €
Operating result275,1 k €68,4 k €487,5 k €575,5 k €951,1 k €584 k €459,3 k €434 k €376,7 k €81,5 k €58,5 k €42,6 k €-107,4 k €
Net result51,7 k €-182,3 k €200,7 k €320,2 k €686,9 k €338,4 k €259,7 k €258,6 k €202,1 k €35,3 k €10,6 k €16,1 k €-110,3 k €
Balance sheet
Equity1,9 M €1,9 M €2,1 M €1,9 M €1,5 M €1 M €697 k €437,3 k €178,7 k €-23,4 k €-58,7 k €-69,3 k €-85,4 k €
Total assets7,8 M €7,6 M €7,6 M €8,5 M €2 M €2,8 M €2,3 M €2,2 M €2,7 M €1,9 M €1,8 M €276,5 k €149,1 k €
Cash1,1 M €1,2 M €749,2 k €145 k €141,4 k €312,4 k €148,1 k €66,2 k €17,2 k €
Debts5,4 M €5,5 M €5,3 M €6,6 M €483,7 k €1,8 M €1,6 M €1,8 M €2,5 M €1,9 M €1,8 M €345,8 k €234,5 k €
Other
Workforce4,7 ETP6,9 ETP10,3 ETP11,3 ETP9,9 ETP10,7 ETP10,5 ETP8,3 ETP7,4 ETP4,0 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 5 ended

Active mandates

Aquitania

Director · since 30 mars 2021 · until 15 juin 2026 · 0666.678.822

Represented by Anja Imschoot

Active
MD CONSULT

Director · since 30 mars 2021 · until 15 juin 2026 · 0471.608.456

Represented by Mario Debel

Active

Ended mandates

Barbara Van den Acker

Director

Ended
Barbara Van den Acker

Manager

Ended
Barbara Van den Ackker

Manager

Ended
Joeri Van den Acker

Director

Ended
At this address

Other companies at this address

CompanyCBE no.
2PHARMAActive
0886.662.746
2PHARMA HOLDINGActive
0644.751.377
0474.817.869
0893.541.630
Ceres InvestActive
0775.683.264
Ceres PharmaActive
0641.953.324
0407.326.754
CONESSENCEActive
0819.266.552
0794.812.555
0681.915.443
DGPharmaActive
0508.925.544
DRIEPUNTNULActive
1021.711.292
HR ESSENTIALSActive
0721.702.467
KOUTERLOSActive
0450.036.349
LabopharActive
0643.723.177
MD PharmaActive
0667.779.672
PADEL FACTORYActive
0801.951.260
0865.651.952
0884.649.304
0421.364.139
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date26/08/202630/07/202525/07/202429/08/202325/08/202203/03/2021
General meeting15/06/202630/06/202530/06/202429/08/202315/07/202219/02/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

13 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202515/06/202626/08/2026DutchPDF
Abridged model31/12/202430/06/202530/07/2025DutchPDF
Abridged model31/12/202330/06/202425/07/2024DutchPDF
Abridged model31/12/202229/08/202329/08/2023DutchPDF
Abridged model31/12/202115/07/202225/08/2022DutchPDF
Abridged model31/12/202019/02/202103/03/2021DutchPDF
Abridged model31/12/201915/06/202001/10/2020DutchPDF
Abridged model31/12/201817/06/201902/09/2019DutchPDF
Abridged model31/12/201729/01/201805/02/2018DutchPDF
Abridged model31/12/201619/06/201731/08/2017DutchPDF
Abridged model30/06/201601/12/201626/01/2017DutchPDF
Abridged model30/06/201503/12/201504/02/2016DutchPDF
Abridged model30/06/201404/12/201412/01/2015DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 5 ended

Active mandates

Aquitania

Director · since 30 mars 2021 · until 15 juin 2026 · 0666.678.822

Represented by Anja Imschoot

Active
MD CONSULT

Director · since 30 mars 2021 · until 15 juin 2026 · 0471.608.456

Represented by Mario Debel

Active

Ended mandates

Barbara Van den Acker

Director

Ended
Barbara Van den Acker

Manager

Ended
Barbara Van den Ackker

Manager

Ended
Joeri Van den Acker

Director

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates03/09/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/12/2022
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other08/11/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates17/05/2021
    ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
    PDF
  • Restructuring12/05/2021
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring23/02/2021
    KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Other31/01/2017
    DOEL - ALGEMENE VERGADERING - BOEKJAAR
    PDF
  • Registered office13/05/2016
    MAATSCHAPPELIJKE ZETEL
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202551,7 k €
  2. 2024
    Annual accounts 2024-182,3 k €
  3. 2023
    Annual accounts 2023200,7 k €
  4. 2022
    Annual accounts 2022320,2 k €
  5. 2021
    Annual accounts 2021686,9 k €
  6. 2020
    Annual accounts 2020338,4 k €
  7. 2019
    Annual accounts 2019259,7 k €
  8. 2018
    Annual accounts 2018258,6 k €
  9. 2017
    Annual accounts 2017202,1 k €
  10. 2016
    Annual accounts 201635,3 k €
  11. 2016
    Annual accounts 201610,6 k €
  12. 2015
    Annual accounts 201516,1 k €
  13. 2014
    Annual accounts 2014-110,3 k €
  14. 16/10/2012
    IncorporationPrivate limited company